SG11201510150VA - Immunotherapy composition and use thereof - Google Patents
Immunotherapy composition and use thereofInfo
- Publication number
- SG11201510150VA SG11201510150VA SG11201510150VA SG11201510150VA SG11201510150VA SG 11201510150V A SG11201510150V A SG 11201510150VA SG 11201510150V A SG11201510150V A SG 11201510150VA SG 11201510150V A SG11201510150V A SG 11201510150VA SG 11201510150V A SG11201510150V A SG 11201510150VA
- Authority
- SG
- Singapore
- Prior art keywords
- immunotherapy composition
- immunotherapy
- composition
- Prior art date
Links
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013902268A AU2013902268A0 (en) | 2013-06-21 | Immunotherapy composition (ii) and use thereof | |
| AU2013902262A AU2013902262A0 (en) | 2013-06-21 | Immunotherapy composition (i) and use thereof | |
| AU2013903925A AU2013903925A0 (en) | 2013-10-11 | Immunotherapy composition (III) and use thereof | |
| AU2013905007A AU2013905007A0 (en) | 2013-12-20 | Immunotherapy composition (II) and use thereof | |
| PCT/AU2014/050087 WO2014201525A1 (en) | 2013-06-21 | 2014-06-20 | Immunotherapy composition and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201510150VA true SG11201510150VA (en) | 2016-01-28 |
Family
ID=52103716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510150VA SG11201510150VA (en) | 2013-06-21 | 2014-06-20 | Immunotherapy composition and use thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9555104B2 (en) |
| EP (1) | EP3010517A4 (en) |
| JP (2) | JP6495256B2 (en) |
| CN (1) | CN105636601A (en) |
| AU (1) | AU2014284047B2 (en) |
| BR (1) | BR112015032033A2 (en) |
| CA (1) | CA2915673C (en) |
| SG (1) | SG11201510150VA (en) |
| WO (1) | WO2014201525A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014284047B2 (en) | 2013-06-21 | 2018-11-22 | Ondek Pty Ltd | Immunotherapy composition and use thereof |
| EP3538558A4 (en) | 2016-11-09 | 2020-07-15 | North Carolina State University | Treatment of allergic diseases with chimeric protein |
| US20210009678A1 (en) * | 2018-03-23 | 2021-01-14 | North Carolina State University | Methods and compositions for allergic disorders |
| WO2021216598A1 (en) * | 2020-04-22 | 2021-10-28 | Yobee Care, Inc. | Methods and compositions for preventing atopic march and treating skin conditions |
| TWI802009B (en) * | 2021-09-16 | 2023-05-11 | 創百股份有限公司 | Treatment and/or prevention of particulate matter-induced lung injury using heat-killed strains of lactic acid bacteria |
| WO2023074607A1 (en) * | 2021-10-25 | 2023-05-04 | インテグリカルチャー株式会社 | Cell holding material, sensor, frame member, and cell holding method |
| CN114292896B (en) * | 2021-12-24 | 2023-08-22 | 四川大学华西医院 | Helicobacter pylori drug sensitivity detection method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008509168A (en) * | 2004-08-13 | 2008-03-27 | マーシャル，バリー，ジェー． | Bacteria delivery system |
| ATE516817T1 (en) * | 2005-06-16 | 2011-08-15 | Univ Gent | VACCINES FOR IMMUNIZATION AGAINST HELICOBACTER |
| CN102176907A (en) * | 2008-10-08 | 2011-09-07 | 免疫解决方案有限公司 | Oral vaccines for producing mucosal immunity |
| BRPI1100857A2 (en) | 2011-03-18 | 2013-05-21 | Alexandre Eduardo Nowill | immunomodulatory agent and combinations thereof, their use and immunotherapeutic method for real time recontextualization, reprogramming and rebuilding of the immune system |
| JP2013116089A (en) * | 2011-12-05 | 2013-06-13 | Nagoya Seiraku Kk | Lactobacillus strain having anti-helicobacter pylori activity, anti-helicobacter pylori medicine containing the lactobacillus strain, and food and drink containing the same |
| CN105392780A (en) | 2013-05-24 | 2016-03-09 | 雀巢产品技术援助有限公司 | Pathway specific assays for predicting irritable bowel syndrome diagnosis |
| AU2014284047B2 (en) | 2013-06-21 | 2018-11-22 | Ondek Pty Ltd | Immunotherapy composition and use thereof |
-
2014
- 2014-06-20 AU AU2014284047A patent/AU2014284047B2/en active Active
- 2014-06-20 JP JP2016520199A patent/JP6495256B2/en active Active
- 2014-06-20 EP EP14813398.6A patent/EP3010517A4/en active Pending
- 2014-06-20 US US14/897,575 patent/US9555104B2/en active Active
- 2014-06-20 BR BR112015032033A patent/BR112015032033A2/en not_active Application Discontinuation
- 2014-06-20 SG SG11201510150VA patent/SG11201510150VA/en unknown
- 2014-06-20 WO PCT/AU2014/050087 patent/WO2014201525A1/en active Application Filing
- 2014-06-20 CA CA2915673A patent/CA2915673C/en active Active
- 2014-06-20 CN CN201480046561.3A patent/CN105636601A/en active Pending
-
2016
- 2016-12-16 US US15/381,485 patent/US10130704B2/en active Active
-
2018
- 2018-12-12 JP JP2018232441A patent/JP2019059770A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2915673A1 (en) | 2014-12-24 |
| US10130704B2 (en) | 2018-11-20 |
| US20170165357A1 (en) | 2017-06-15 |
| CA2915673C (en) | 2021-10-12 |
| BR112015032033A2 (en) | 2017-08-29 |
| EP3010517A4 (en) | 2017-04-26 |
| CN105636601A (en) | 2016-06-01 |
| EP3010517A1 (en) | 2016-04-27 |
| US9555104B2 (en) | 2017-01-31 |
| JP2019059770A (en) | 2019-04-18 |
| US20160175429A1 (en) | 2016-06-23 |
| JP6495256B2 (en) | 2019-04-03 |
| AU2014284047A1 (en) | 2016-02-04 |
| AU2014284047B2 (en) | 2018-11-22 |
| WO2014201525A1 (en) | 2014-12-24 |
| JP2016522222A (en) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289821B (en) | Compositions and methods for immunotherapy | |
| HK1223975A1 (en) | Nanobubble-containing composition and use thereof | |
| HK1220387A1 (en) | Compositions and methods for immunotherapy | |
| GB201317286D0 (en) | Composition and Use | |
| GB201305277D0 (en) | Novel combination and use | |
| IL285527A (en) | Compositions and methods for immunotherapy | |
| GB201321693D0 (en) | Composition and uses thereof | |
| GB201301626D0 (en) | Composition comprising 15-OHEPA and methods of using the same | |
| SG11201600275PA (en) | Novel adsorbent composition and use thereof | |
| SG11201510150VA (en) | Immunotherapy composition and use thereof | |
| PL2910131T3 (en) | Anti-fatigue composition and use thereof | |
| IL240090A0 (en) | Compositions comprising l-4-chlorokynurenine and uses thereof | |
| EP2964610A4 (en) | Vinylsulfone-based 18f-labeling compositions and methods and uses thereof | |
| GB201301979D0 (en) | New composition and use thereof | |
| GB201307989D0 (en) | Novel combinations and use | |
| GB201318151D0 (en) | Composition and device | |
| ZA201602043B (en) | Novel immunotherapeutic composition and uses thereof | |
| GB2532383B (en) | Set-delayed cement compositions comprising pumice and associated methods | |
| GB201322467D0 (en) | Composition and use | |
| GB201301022D0 (en) | Composition and uses thereof | |
| AU2013905007A0 (en) | Immunotherapy composition (II) and use thereof | |
| AU2013902268A0 (en) | Immunotherapy composition (ii) and use thereof | |
| AU2013903925A0 (en) | Immunotherapy composition (III) and use thereof | |
| AU2013902262A0 (en) | Immunotherapy composition (i) and use thereof | |
| GB201313605D0 (en) | Novel compounds and their use |